Businessweek

ULURU Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, the company’s total revenues were $102,044 against $60,005 a year ago. Operating loss was $547,369 against $819,712 a year ago. Loss before income taxes was $656,590 against $843,409 a year ago. Net loss was $656,590 against $843,409 a year ago. Net loss allocable to common stockholders was $668,611 or $0.06 basic and diluted per share against $854,135 or $0.11 basic and diluted per share a year ago. The increase of $42,000 in revenues is primarily attributable to an increase of $55,000 in Altrazeal(R) product sales.

ULURU Inc., Q1 2013 Earnings Call, May 20, 2013

ULURU Inc. reported unaudited consolidated results for the fourth quarter and year ended December 31, 2012. For the quarter, the company’s total revenues were $165,456 against $255,527 a year ago. Operating loss was $868,803 against $839,206 a year ago. Loss before income taxes was $978,069 against $855,811 a year ago. Net loss was $978,069 against $855,811 a year ago. Net loss allocable to common stockholders was $990,357 or $0.10 basic and diluted per share against $859,736 or $0.13 basic and diluted per share a year ago. For the year, the company’s total revenues were $370,594 against $484,536 a year ago. Operating loss was $3,264,820 against $4,014,133 a year ago. Loss before income taxes was $3,531,349 against $4,070,092 a year ago. Net loss was $3,531,349 against $4,070,092 a year ago. Net loss allocable to common stockholders was $3,578,805 or $0.42 basic and diluted per share against $4,074,479 or $0.67 basic and diluted per share a year ago. For the fourth quarter 2013, the company projects cash flow positive by the fourth quarter of 2013. For the full year 2013, the company projects increase in revenues for 2013, and forecasts a significant improvement in operating results.

ULURU Inc., Q4 2012 Earnings Call, Apr 01, 2013

ULURU Inc. announced the appointment of Helmut Kerschbaumer and Klaus Kuehne as members of the board of directors of the company. As part of the previously announced strategic relationship with an affiliate of Melmed Holding AG, IPMD GmbH made an equity investment of $2 million in ULURU Inc., and was granted the right to appoint two members of the Board of Directors.